GAAP Net Loss of $0.33 Per Diluted Share for the First Quarter FFO, As Adjusted of $0.15 Per Diluted Share for the First Quarter Office Same Store NOI Growth of 0.7% (Cash)Positive Office New Lease Spreads of 9.6% (GAAP) and 7.2% (Cash) Retail Same Store NOI Growth of 2.2% (Cash)Positive Retail Renewal Spreads of 10.7% (GAAP) and 4.5% (Cash) VIRGINIA BEACH, Va., May 04, 2026 (GLOBE NEWSWIRE) — AH Realty Trust (NYSE: AHRT) today announced its results for the quarter ended March 31, 2026 and provided an update on current events and earnings guidance. First Quarter and Recent Highlights:On February 16, 2026, we announced a fundamental business restructuring to eliminate complexity, strengthen the balance sheet, and relentlessly focus on operating a streamlined real estate platform. The restructuring includes:Exiting the multifamily...

Grows Q1 revenue 15% year-over-year to $190.9 million Delivers net income of $18.7 million Drives record Adjusted EBITDA of $29.3 million, marking growth of 30% year-over-year Exceeds guidance across all metrics Provides Q2 outlook reflecting 21% revenue growth at the midpointCAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading provider of growth solutions for property and casualty, or P&C, insurance providers, today announced financial results for the first quarter ended March 31, 2026. “Our first quarter results demonstrate our strong performance and favorable sector demand as we execute our mission to empower P&C insurance providers to grow market share by maximizing customer acquisition across digital channels,” said Jayme Mendal, CEO of EverQuote. “As we look to the remainder...

BOULDER, Colo., May 04, 2026 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary vs First Quarter 2025 (where applicable)Revenue increased to $24.3 million compared to $23.8 million. Gross profit remained flat at $20.9 million. Generated $1.5 million in operating cash flow and $1.1 million in free cash flow.Management Commentary “This quarter reflects a deliberate step in how we are positioning Gaia for long-term success,” said Kiersten Medvedich, Chief Executive Officer of Gaia. “As we’ve evaluated the business, it has become clear that our greatest opportunity lies in deepening our direct relationship with members, where we can deliver the full Gaia experience and capture significantly stronger...

First quarter revenue growth of 1.6% First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10 First quarter operating cash flow of $12.8 millionMINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2026. “Our first quarter results reflect revenue growth and improved adjusted operating income and cash flow,” said Tim Herbert, Chairman and CEO of Inspire Medical Systems. “We remain focused on the factors within our control, including prioritizing revenue-generating activities and maintaining disciplined cost management, while continuing...

Highlights (All comparisons are to the prior year period unless otherwise noted):Net sales of $528.8 million for the quarter, up 4.2% Diluted earnings per share (“EPS”) of $1.43, down 24% Adjusted diluted EPS* of $1.57, down 22% Generated $43.8 million of cash from operating activities; repurchased $51 million of its sharesCOLMAR, Pa., May 04, 2026 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry, today announced its financial results for the first quarter ended March 28, 2026. Kevin Olsen, Dorman’s Chairman, President, and Chief Executive Officer, stated, “We started the year with solid financial performance that was in line with our expectations. Despite ongoing uncertainty in the broader economy and geopolitical environment, we...

Delivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in Q1 2026; Increased FY 2026 Revenue Guidance to $108-114 million, mid-point reflects 25% growth; Conference Call and Webcast Today at 4:30 p.m. ET LOUISVILLE, Colo., May 04, 2026 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the first quarter ended March 31, 2026. “Biodesix delivered exceptional first quarter results that reflect strong momentum across both our Diagnostic Testing and our Development Services business,” said Scott Hutton, Chief Executive Officer. “Test volumes grew 29%, Development Services revenue doubled, and average revenue per test increased through expanded payer coverage and improved revenue cycle management,...

All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, May 04, 2026 (GLOBE NEWSWIRE) — Gibson Energy Inc. (TSX:GEI) (“Gibson” or the “Company”) announced today its financial and operating results for the three months ended March 31, 2026.Key Highlights:Expanded core infrastructure footprint with the $400 million Chauvin acquisition, strengthening the long-term growth platform, and sanctioned the Hardisty Connection growth project, which will enhance and extend connectivity at the terminal Successfully completed a $215 million equity financing, which partially funded the Chauvin acquisition, reflecting our commitment to capital discipline Delivered quarterly Infrastructure EBITDA(1) of $156 million, consistent with the prior year Completed organizational restructuring...

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)4 May 2026 –  Theon International Plc (THEON) is pleased to announce that it has agreed on binding terms, having entered into an exclusivity agreement with the sole shareholder of Merio SAS (MERIO), RPL Développement, to acquire upfront an 80% stake of MERIO. The conclusion of the transaction is subject to consummation of long-form documentation and customary closing conditions, including regulatory approvals. The transaction will be financed through a combination of debt and internally generated cash. Foreseen Deal Structure THEON to acquire 80% of MERIO at an accretive EBIT multiple. MERIO is expected to generate above €15 million in revenues in FY 2026 and a projected EBIT of above €3.5 million. The management team and key employees will remain in the business. Company Profile MERIO...

Admaxxer announced four operating milestones for the first quarter of 2026, including 5,000 active direct-to-consumer brands, $1.2 billion in cumulative tracked gross merchandise value, a 92% Conversions API match rate, and the launch of bring-your-own-key support for 10 large-language-model providers and a Model Context Protocol server. Wilmington, Delaware, May 04, 2026 (GLOBE NEWSWIRE) — Admaxxer, a direct-to-consumer (DTC) analytics and AI ad operations platform, today reported four operating milestones for the first quarter of 2026, per the company’s Q1 2026 platform metrics report (published at https://admaxxer.com/methodology):Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform5,000 active brands on the platform,...

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that it will host a webcast on Monday, May 11, 2026, at 4:30 p.m. EDT to report its first quarter 2026 financial results and recent corporate highlights. To participate in the conference call via telephone, dial (800) 715-9871 (Domestic) or (646) 307-1963 (International) and enter code 1358554. The live webcast can be accessed here and on the LENZ Therapeutics website at www.LENZ-tx.com in the Investors & Media section. A replay of the webcast will be available on the Company’s website for 30...